Iconovo AB
Develops dry powder inhalers and drug formulations for respiratory diseases.
ICO | ST
Overview
Corporate Details
- ISIN(s):
- SE0010868943 (+3 more)
- LEI:
- 549300CH7SEE52V2WD15
- Country:
- Sweden
- Address:
- Ideongatan 3B, 223 70 Lund
- Website:
- https://iconovo.se/
Description
Iconovo is a company that develops inhaled medicinal products in collaboration with pharmaceutical partners. It specializes in creating complete inhalation solutions, which include both patented dry powder inhalers (DPIs) and the corresponding drug formulations. The company's proprietary inhaler platforms, such as the multi-dose ICOres and the capsule-based ICOcap, are designed for treating respiratory diseases like asthma and Chronic Obstructive Pulmonary Disease (COPD). Iconovo offers an integrated development service, providing expertise from concept to commercial production, and licenses its technology to international pharmaceutical companies to bring new therapies to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Iconovo AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Iconovo AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Iconovo AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
